Evenity® Europe In Europe, EVENITY® (romosozumab) is indicated in the treatment of severe osteoporosis in postmenopausal women at high risk of fracture. Prescribing information Europe EVENITY® SmPC Europe (Sourced from www.ema.europa.eu)